阳光诺和：一审胜诉，恒生制药被判向公司支付215万欠款

Core Viewpoint - Recently, Sunshine Nuohuo announced that it received a first-instance judgment from the Intermediate People's Court of Hengyang City, Hunan Province, ordering Hengsheng Pharmaceutical Co., Ltd. to pay overdue research and development fees totaling 2.15 million yuan and corresponding late payment penalties [1] Group 1: Legal Proceedings - The court ruled that Hengsheng Pharmaceutical must pay Sunshine Nuohuo a total of 2.15 million yuan for overdue R&D fees [1] - Sunshine Nuohuo has filed a lawsuit against Hengsheng Pharmaceutical regarding overdue R&D fees for a total of 24 products, including "Aminobromide Hydrochloride Injection (2ml: 15mg)" and "Clindamycin Phosphate Injection (2ml: 0.3g, 4ml: 0.6g)" [1]